Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger R Reddel

Showing results (101-110 of 142) with videos related to

Pageof 15
Sort By:
Nucleic Acids Research|July 5, 2011
MicroRNA-296 is enriched in cancer cells and downregulates p21WAF1 mRNA expression via interaction with its 3' untranslated regionA-rum Yoon, Ran Gao, Zeenia Kaul, et al.
Cancers|November 13, 2021
The C-Circle Biomarker Is Secreted by Alternative-Lengthening-of-Telomeres Positive Cancer Cells inside Exosomes and Provides a Blood-Based Diagnostic for ALT ActivityYuan-Yin Chen, Rebecca Dagg, Yuchen Zhang, et al.
Cancer Research|July 5, 2006
Association of mutant TP53 with alternative lengthening of telomeres and favorable prognosis in gliomaYu-Jen Chen, Vicky Hakin-Smith, Mario Teo, et al.
Plos One|October 11, 2012
Extreme telomere length dimorphism in the Tasmanian devil and related marsupials suggests parental control of telomere lengthHannah S Bender, Elizabeth P Murchison, Hilda A Pickett, et al.
EMBO Molecular Medicine|August 3, 2022
TOP3A amplification and ATRX inactivation are mutually exclusive events in pediatric osteosarcomas using ALTAlexandre de Nonneville, Sébastien Salas, François Bertucci, et al.
Blood|September 11, 2014
Inherited bone marrow failure associated with germline mutation of ACD, the gene encoding telomere protein TPP1Yiran Guo, Melissa Kartawinata, Jiankang Li, et al.
Journal of Neuropathology and Experimental Neurology|June 11, 2010
Presence of alternative lengthening of telomeres mechanism in patients with glioblastoma identifies a less aggressive tumor type with longer survivalKerrie L McDonald, Julie McDonnell, Alessandra Muntoni, et al.
Cell Reports|June 22, 2017
Extensive Proliferation of Human Cancer Cells with Ever-Shorter TelomeresRebecca A Dagg, Hilda A Pickett, Axel A Neumann, et al.
Ejhaem|July 18, 2022
A novel cause of <i>DKC1</i>-related bone marrow failure: Partial deletion of the 3' untranslated regionJonathan W Arthur, Hilda A Pickett, Pasquale M Barbaro, et al.
NPJ Breast Cancer|May 28, 2026
Potential treatment targets in the whole-tissue proteome of triple negative breast cancerTram B Doan, Merridee A Wouters, Jiashu Hu, et al.
Pageof 15

Showing results (101-110 of 142) with videos related to

Sort By:
Pageof 15
Nucleic Acids Research|July 5, 2011
MicroRNA-296 is enriched in cancer cells and downregulates p21WAF1 mRNA expression via interaction with its 3' untranslated regionA-rum Yoon, Ran Gao, Zeenia Kaul, et al.
Cancers|November 13, 2021
The C-Circle Biomarker Is Secreted by Alternative-Lengthening-of-Telomeres Positive Cancer Cells inside Exosomes and Provides a Blood-Based Diagnostic for ALT ActivityYuan-Yin Chen, Rebecca Dagg, Yuchen Zhang, et al.
Cancer Research|July 5, 2006
Association of mutant TP53 with alternative lengthening of telomeres and favorable prognosis in gliomaYu-Jen Chen, Vicky Hakin-Smith, Mario Teo, et al.
Plos One|October 11, 2012
Extreme telomere length dimorphism in the Tasmanian devil and related marsupials suggests parental control of telomere lengthHannah S Bender, Elizabeth P Murchison, Hilda A Pickett, et al.
EMBO Molecular Medicine|August 3, 2022
TOP3A amplification and ATRX inactivation are mutually exclusive events in pediatric osteosarcomas using ALTAlexandre de Nonneville, Sébastien Salas, François Bertucci, et al.
Blood|September 11, 2014
Inherited bone marrow failure associated with germline mutation of ACD, the gene encoding telomere protein TPP1Yiran Guo, Melissa Kartawinata, Jiankang Li, et al.
Journal of Neuropathology and Experimental Neurology|June 11, 2010
Presence of alternative lengthening of telomeres mechanism in patients with glioblastoma identifies a less aggressive tumor type with longer survivalKerrie L McDonald, Julie McDonnell, Alessandra Muntoni, et al.
Cell Reports|June 22, 2017
Extensive Proliferation of Human Cancer Cells with Ever-Shorter TelomeresRebecca A Dagg, Hilda A Pickett, Axel A Neumann, et al.
Ejhaem|July 18, 2022
A novel cause of <i>DKC1</i>-related bone marrow failure: Partial deletion of the 3' untranslated regionJonathan W Arthur, Hilda A Pickett, Pasquale M Barbaro, et al.
NPJ Breast Cancer|May 28, 2026
Potential treatment targets in the whole-tissue proteome of triple negative breast cancerTram B Doan, Merridee A Wouters, Jiashu Hu, et al.
Pageof 15